XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls

BACKGROUND: Previous studies have investigated the correlation between xeroderma pigmentosumcomplementation group C (XPC) variants and prostate adenocarcinoma (PA) risk. Nevertheless, research findings remain inconclusive. METHODS: We conducted a pooled analysis to obtain a more accurate estimation...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Feng, Gao, Sheng-Lin, Xu, Kai, Su, Quan-Xin, Zhang, Ze, Shi, Li, Zhu, Li-Jie, Zhang, Li-Feng, Zuo, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360297/
https://www.ncbi.nlm.nih.gov/pubmed/32664151
http://dx.doi.org/10.1097/MD.0000000000021160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360297/
https://www.ncbi.nlm.nih.gov/pubmed/32664151
http://dx.doi.org/10.1097/MD.0000000000021160

Ejemplares similares